Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nervous System Tumors”

7,020 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,020 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableStudy completedNCT04190342
What this trial is testing

Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients

Who this might be right for
Breast Neoplasm FemaleSymptom ClusterTai ji
Charles Darwin University 72
Large-scale testing (Phase 3)Active Not RecruitingNCT05644561
What this trial is testing

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Not applicableUnknownNCT05981170
What this trial is testing

Rurality Adapted Physical Activity Sport Health

Who this might be right for
Brain TumourMetastatic Cancer
Institut Cancerologie de l'Ouest 10
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Looking for participantsNCT07688356
What this trial is testing

Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors

Who this might be right for
Primary Brain TumorMetastatic Brain Tumor
Samsung Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01783522
What this trial is testing

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Who this might be right for
Chemotherapeutic Agent ToxicityMultiple MyelomaPeripheral Neuropathy
Beth Faiman 9
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Not applicableLooking for participantsNCT05831631
What this trial is testing

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Who this might be right for
Brain Tumor, PrimaryBrain Tumor - Metastatic
Pietro Mortini, MD, Prof. 200
Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Not applicableActive Not RecruitingNCT05388370
What this trial is testing

PASS of Paediatric Patients Initiating Selumetinib

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 124
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Very early researchStudy completedNCT00657202
What this trial is testing

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT00001595
What this trial is testing

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Who this might be right for
PanhypopituitarismGigantism/AcromegalyProlactinoma+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,000
Early research (Phase 1)Study completedNCT00437372
What this trial is testing

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Who this might be right for
CancerHead and Neck CancerPelvic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Not applicableLooking for participantsNCT06148077
What this trial is testing

Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors

Who this might be right for
Head and Neck CancerTrismusDysfunction
Universidad de La Frontera 70
Not applicableEnded earlyNCT00629395
What this trial is testing

Computerized Cognitive Training for Childhood Cancer Survivors

Who this might be right for
Primary Brain Tumor
Duke University 9
Not applicableStudy completedNCT02948751
What this trial is testing

Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

Who this might be right for
Breast CancerLeptomeningeal Metastasis
Columbia University 14
Next Page